DOLBY LABORATORIES INC-CL A (DLB) Fundamental Analysis & Valuation

NYSE:DLB • US25659T1079

Current stock price

57.46 USD
-6.68 (-10.41%)
At close:
57.54 USD
+0.08 (+0.14%)
After Hours:

This DLB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. DLB Profitability Analysis

1.1 Basic Checks

  • DLB had positive earnings in the past year.
  • DLB had a positive operating cash flow in the past year.
  • DLB had positive earnings in each of the past 5 years.
  • In the past 5 years DLB always reported a positive cash flow from operatings.
DLB Yearly Net Income VS EBIT VS OCF VS FCFDLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • With a decent Return On Assets value of 7.53%, DLB is doing good in the industry, outperforming 79.78% of the companies in the same industry.
  • DLB's Return On Equity of 9.27% is fine compared to the rest of the industry. DLB outperforms 72.79% of its industry peers.
  • DLB has a Return On Invested Capital of 8.23%. This is amongst the best in the industry. DLB outperforms 80.51% of its industry peers.
  • DLB had an Average Return On Invested Capital over the past 3 years of 8.50%. This is below the industry average of 11.04%.
Industry RankSector Rank
ROA 7.53%
ROE 9.27%
ROIC 8.23%
ROA(3y)7.69%
ROA(5y)7.98%
ROE(3y)9.61%
ROE(5y)9.79%
ROIC(3y)8.5%
ROIC(5y)8.69%
DLB Yearly ROA, ROE, ROICDLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • DLB's Profit Margin of 17.97% is amongst the best of the industry. DLB outperforms 84.19% of its industry peers.
  • DLB's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 19.98%, DLB belongs to the top of the industry, outperforming 87.13% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DLB has grown nicely.
  • DLB has a Gross Margin of 87.86%. This is amongst the best in the industry. DLB outperforms 94.85% of its industry peers.
  • DLB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.98%
PM (TTM) 17.97%
GM 87.86%
OM growth 3Y6.2%
OM growth 5Y1.8%
PM growth 3Y8.78%
PM growth 5Y-1.04%
GM growth 3Y-0.22%
GM growth 5Y0.17%
DLB Yearly Profit, Operating, Gross MarginsDLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

9

2. DLB Health Analysis

2.1 Basic Checks

  • DLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • DLB has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for DLB has been reduced compared to 5 years ago.
  • DLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DLB Yearly Shares OutstandingDLB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
DLB Yearly Total Debt VS Total AssetsDLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • DLB has an Altman-Z score of 8.34. This indicates that DLB is financially healthy and has little risk of bankruptcy at the moment.
  • DLB's Altman-Z score of 8.34 is amongst the best of the industry. DLB outperforms 86.76% of its industry peers.
  • DLB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.34
ROIC/WACC0.75
WACC10.94%
DLB Yearly LT Debt VS Equity VS FCFDLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • A Current Ratio of 3.17 indicates that DLB has no problem at all paying its short term obligations.
  • The Current ratio of DLB (3.17) is better than 73.53% of its industry peers.
  • A Quick Ratio of 3.10 indicates that DLB has no problem at all paying its short term obligations.
  • DLB's Quick ratio of 3.10 is fine compared to the rest of the industry. DLB outperforms 73.53% of its industry peers.
Industry RankSector Rank
Current Ratio 3.17
Quick Ratio 3.1
DLB Yearly Current Assets VS Current LiabilitesDLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. DLB Growth Analysis

3.1 Past

  • DLB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.00%.
  • DLB shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.55% yearly.
  • Looking at the last year, DLB shows a small growth in Revenue. The Revenue has grown by 5.92% in the last year.
  • The Revenue has been growing slightly by 3.03% on average over the past years.
EPS 1Y (TTM)5%
EPS 3Y10.5%
EPS 5Y8.55%
EPS Q2Q%2.24%
Revenue 1Y (TTM)5.92%
Revenue growth 3Y2.47%
Revenue growth 5Y3.03%
Sales Q2Q%7.05%

3.2 Future

  • Based on estimates for the next years, DLB will show a small growth in Earnings Per Share. The EPS will grow by 6.48% on average per year.
  • Based on estimates for the next years, DLB will show a small growth in Revenue. The Revenue will grow by 4.93% on average per year.
EPS Next Y3.08%
EPS Next 2Y4.93%
EPS Next 3Y6.48%
EPS Next 5YN/A
Revenue Next Year5.37%
Revenue Next 2Y4.6%
Revenue Next 3Y4.93%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DLB Yearly Revenue VS EstimatesDLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
DLB Yearly EPS VS EstimatesDLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

5

4. DLB Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.68, the valuation of DLB can be described as correct.
  • DLB's Price/Earnings ratio is a bit cheaper when compared to the industry. DLB is cheaper than 78.31% of the companies in the same industry.
  • DLB is valuated rather cheaply when we compare the Price/Earnings ratio to 26.64, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 12.28, the valuation of DLB can be described as correct.
  • Based on the Price/Forward Earnings ratio, DLB is valued a bit cheaper than 77.21% of the companies in the same industry.
  • DLB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.36, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.68
Fwd PE 12.28
DLB Price Earnings VS Forward Price EarningsDLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 78.31% of the companies in the same industry are more expensive than DLB, based on the Enterprise Value to EBITDA ratio.
  • 78.31% of the companies in the same industry are more expensive than DLB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.46
EV/EBITDA 15.35
DLB Per share dataDLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • DLB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.44
PEG (5Y)1.6
EPS Next 2Y4.93%
EPS Next 3Y6.48%

7

5. DLB Dividend Analysis

5.1 Amount

  • DLB has a Yearly Dividend Yield of 2.28%.
  • Compared to an average industry Dividend Yield of 0.67, DLB pays a better dividend. On top of this DLB pays more dividend than 94.85% of the companies listed in the same industry.
  • DLB's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.28%

5.2 History

  • The dividend of DLB is nicely growing with an annual growth rate of 8.45%!
  • DLB has been paying a dividend for at least 10 years, so it has a reliable track record.
  • DLB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.45%
Div Incr Years11
Div Non Decr Years11
DLB Yearly Dividends per shareDLB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • DLB pays out 53.80% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of DLB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP53.8%
EPS Next 2Y4.93%
EPS Next 3Y6.48%
DLB Yearly Income VS Free CF VS DividendDLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
DLB Dividend Payout.DLB Dividend Payout, showing the Payout Ratio.DLB Dividend Payout.PayoutRetained Earnings

DLB Fundamentals: All Metrics, Ratios and Statistics

DOLBY LABORATORIES INC-CL A

NYSE:DLB (5/1/2026, 8:22:00 PM)

After market: 57.54 +0.08 (+0.14%)

57.46

-6.68 (-10.41%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Industry Strength6.83
Industry Growth86.34
Earnings (Last)04-30
Earnings (Next)N/A
Inst Owners99.37%
Inst Owner Change0.49%
Ins Owners1.28%
Ins Owner Change7.24%
Market Cap5.49B
Revenue(TTM)1.35B
Net Income(TTM)240.52M
Analysts80
Price Target89.58 (55.9%)
Short Float %6.96%
Short Ratio6.51
Dividend
Industry RankSector Rank
Dividend Yield 2.28%
Yearly Dividend1.33
Dividend Growth(5Y)8.45%
DP53.8%
Div Incr Years11
Div Non Decr Years11
Ex-Date02-10
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.87%
Min EPS beat(2)19.71%
Max EPS beat(2)40.03%
EPS beat(4)4
Avg EPS beat(4)18.19%
Min EPS beat(4)4.74%
Max EPS beat(4)40.03%
EPS beat(8)8
Avg EPS beat(8)14.94%
EPS beat(12)11
Avg EPS beat(12)15.41%
EPS beat(16)14
Avg EPS beat(16)15.04%
Revenue beat(2)1
Avg Revenue beat(2)1.53%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)3.3%
Revenue beat(4)2
Avg Revenue beat(4)0.66%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)3.3%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)5
Avg Revenue beat(12)0.53%
Revenue beat(16)6
Avg Revenue beat(16)0.12%
PT rev (1m)0%
PT rev (3m)-2.96%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.97%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)2.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE 13.68
Fwd PE 12.28
P/S 4.1
P/FCF 14.46
P/OCF 13.06
P/B 2.12
P/tB 3.23
EV/EBITDA 15.35
EPS(TTM)4.2
EY7.31%
EPS(NY)4.68
Fwd EY8.14%
FCF(TTM)3.97
FCFY6.92%
OCF(TTM)4.4
OCFY7.65%
SpS14.01
BVpS27.15
TBVpS17.79
PEG (NY)4.44
PEG (5Y)1.6
Graham Number50.6502 (-11.85%)
Profitability
Industry RankSector Rank
ROA 7.53%
ROE 9.27%
ROCE 9.73%
ROIC 8.23%
ROICexc 10.75%
ROICexgc 18.7%
OM 19.98%
PM (TTM) 17.97%
GM 87.86%
FCFM 28.36%
ROA(3y)7.69%
ROA(5y)7.98%
ROE(3y)9.61%
ROE(5y)9.79%
ROIC(3y)8.5%
ROIC(5y)8.69%
ROICexc(3y)11.58%
ROICexc(5y)13.02%
ROICexgc(3y)19.56%
ROICexgc(5y)20.42%
ROCE(3y)10.05%
ROCE(5y)10.27%
ROICexgc growth 3Y7.72%
ROICexgc growth 5Y2.66%
ROICexc growth 3Y-0.34%
ROICexc growth 5Y-1.41%
OM growth 3Y6.2%
OM growth 5Y1.8%
PM growth 3Y8.78%
PM growth 5Y-1.04%
GM growth 3Y-0.22%
GM growth 5Y0.17%
F-Score7
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.24%
Cap/Sales 3.03%
Interest Coverage 250
Cash Conversion 117.67%
Profit Quality 157.85%
Current Ratio 3.17
Quick Ratio 3.1
Altman-Z 8.34
F-Score7
WACC10.94%
ROIC/WACC0.75
Cap/Depr(3y)41.38%
Cap/Depr(5y)49.64%
Cap/Sales(3y)2.6%
Cap/Sales(5y)3.36%
Profit Quality(3y)150.02%
Profit Quality(5y)143.52%
High Growth Momentum
Growth
EPS 1Y (TTM)5%
EPS 3Y10.5%
EPS 5Y8.55%
EPS Q2Q%2.24%
EPS Next Y3.08%
EPS Next 2Y4.93%
EPS Next 3Y6.48%
EPS Next 5YN/A
Revenue 1Y (TTM)5.92%
Revenue growth 3Y2.47%
Revenue growth 5Y3.03%
Sales Q2Q%7.05%
Revenue Next Year5.37%
Revenue Next 2Y4.6%
Revenue Next 3Y4.93%
Revenue Next 5YN/A
EBIT growth 1Y-3.6%
EBIT growth 3Y8.83%
EBIT growth 5Y4.89%
EBIT Next Year23.78%
EBIT Next 3Y11.88%
EBIT Next 5YN/A
FCF growth 1Y30.96%
FCF growth 3Y18.42%
FCF growth 5Y9.38%
OCF growth 1Y31.68%
OCF growth 3Y14.01%
OCF growth 5Y6.55%

DOLBY LABORATORIES INC-CL A / DLB Fundamental Analysis FAQ

What is the fundamental rating for DLB stock?

ChartMill assigns a fundamental rating of 7 / 10 to DLB.


What is the valuation status for DLB stock?

ChartMill assigns a valuation rating of 5 / 10 to DOLBY LABORATORIES INC-CL A (DLB). This can be considered as Fairly Valued.


How profitable is DOLBY LABORATORIES INC-CL A (DLB) stock?

DOLBY LABORATORIES INC-CL A (DLB) has a profitability rating of 7 / 10.


What is the valuation of DOLBY LABORATORIES INC-CL A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for DOLBY LABORATORIES INC-CL A (DLB) is 13.68 and the Price/Book (PB) ratio is 2.12.


What is the expected EPS growth for DOLBY LABORATORIES INC-CL A (DLB) stock?

The Earnings per Share (EPS) of DOLBY LABORATORIES INC-CL A (DLB) is expected to grow by 3.08% in the next year.